A study has shown that treatment with Sitagliptin does not increase the risks of major cardiovascular events or hospitalisation for heart failure
MSD, known as...
Following the release of the Environmental Investigation Agency (EIA) and PremiCongo’s groundbreaking report Toxic Transition, and allegations that the world’s...